about
Antimalarial drug resistance: An overviewAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkDrug resistance genomics of the antimalarial drug artemisininThe interplay between drug resistance and fitness in malaria parasitesUDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genesA genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaSelection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina FasoImproving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsA process similar to autophagy is associated with cytocidal chloroquine resistance in Plasmodium falciparumMetabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolismMolecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance TransporterEvolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole PhysiologyHemozoin and antimalarial drug discoveryMultiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sitesDrug resistance in eukaryotic microorganisms.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataA Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineQuinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparumDifferential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda.Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal.Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strainsPlasmodium falciparum chloroquine resistance transporter is a H+-coupled polyspecific nutrient and drug exporter.Antiparasitic chemotherapy: from genomes to mechanisms.Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter.Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities.Imaging flow cytometry analysis of intracellular pathogens.Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliBioisosteric ferrocenyl-containing quinolines with antiplasmodial and antitrichomonal properties.Genetic polymorphisms in Plasmodium falciparum chloroquine resistance genes, pfcrt and pfmdr1, in North Sulawesi, Indonesia.Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.Tricks in Plasmodium's molecular repertoire--escaping 3'UTR excision-based conditional silencing of the chloroquine resistance transporter gene.Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages.Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia.Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
P2860
Q26753085-5E2CA0A8-7898-4B13-90C6-072C010B1405Q26799713-1D4EB174-CC6E-47C2-82B5-B0EE8C06663FQ26862789-52582D06-F8EB-44AE-9200-4A1E8D794B2CQ26998596-297AA0AC-C9E5-48BA-B8D0-6EE3B478B5BDQ27861953-2C2352D2-5BD9-4882-986F-298F41426434Q28031418-10FA6130-9050-4241-A0C6-3340E2846554Q28125901-0D2D163D-94BE-4219-8852-A87A2A32BE90Q28534701-78F59F98-1AAE-475C-95FC-A6BA0EAABCD3Q28535307-DBC81D4E-02CE-438D-80B9-300B40700EBBQ28538247-7839D597-2566-4A40-A713-3EE8AA8B08C3Q28552775-FA0DAF2D-AA78-46A7-84FE-5EA5387C4079Q28553454-0FEE70E0-3401-4D8A-BA39-2B6C889F6572Q28828253-B03003D8-2117-4C00-BE1A-78610ED2FC80Q30041687-21D66349-DAEE-4F55-9727-AA8C3C689408Q30248243-6F6AC044-9DA0-44FA-9A70-43E27EE00BA5Q30936416-C832E295-5536-4D02-8AE4-352BE6B3EFBBQ33654512-8F9C329F-0995-4380-97C5-FAC104263942Q33797050-0441C59B-5A46-408B-A256-E302451CE5A3Q34169765-3C8B5C50-38D0-406E-806F-DF95EA800FB8Q34651627-2B2560BA-FD37-462C-85B2-BF84F56D301BQ35106020-CCD61225-B80F-4ED0-BD73-2C4138CB3235Q35212623-524CD845-2567-49F6-834A-3420208D50BFQ35238319-6A5E1148-9762-4AEA-BDD2-68CDE29EB4D5Q35607844-8087D770-F261-46AD-BCD3-D047482A8239Q35829555-3E273E0D-A660-4B21-95A3-51C61505C726Q35879787-09ED7E10-FD97-496E-97C1-8316AED97189Q36106723-65F3ACE1-99F3-4449-9643-1452DB58FC9CQ36136833-AE5C4501-CB03-4926-9282-7842DB29CA12Q36143003-2CE82594-173B-4315-B49C-95395C862C65Q36196182-B943D63E-611E-4A33-93B3-4F81354EFD72Q36334947-F4F7B8EE-EF11-4633-BD8E-76645F9B975CQ36378251-B77366BB-5C0F-4286-9287-9E5478954B7CQ36454780-22B238DD-68A6-45A8-A38E-389EF4ADE306Q36724073-8FD5B51E-916C-487F-8CC1-7EFB54028C02Q36904205-23C187C0-50D5-4C48-9C9E-7844D4727027Q36919648-BE527B0E-C275-4F85-B5CF-E76185131B98Q37287899-039458F9-F760-4A3B-83AA-745D5D790138Q37350934-CDB92E59-A6C3-4864-B700-DC7812D82D08Q37425838-BBA94130-5339-477A-B0AB-AA16A3D053CFQ37544359-92788FD5-CD49-4F35-8432-6112ABAE700F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
PfCRT and its role in antimalarial drug resistance
@ast
PfCRT and its role in antimalarial drug resistance
@en
PfCRT and its role in antimalarial drug resistance
@nl
type
label
PfCRT and its role in antimalarial drug resistance
@ast
PfCRT and its role in antimalarial drug resistance
@en
PfCRT and its role in antimalarial drug resistance
@nl
prefLabel
PfCRT and its role in antimalarial drug resistance
@ast
PfCRT and its role in antimalarial drug resistance
@en
PfCRT and its role in antimalarial drug resistance
@nl
P2860
P50
P921
P3181
P356
P1476
PfCRT and its role in antimalarial drug resistance
@en
P2093
Andrea Ecker
P2860
P304
P3181
P356
10.1016/J.PT.2012.08.002
P577
2012-11-01T00:00:00Z